jag009
★★★

NJ,
2012-05-16 18:22
(5139 d 00:38 ago)

Posting: # 8577
Views: 2,842
 

 FDA: In-Vitro Alcohol testing of modified release product [Regulatives / Guidelines]

Hi everyone,

Does anyone have experience with the in-vitro EtOH testing on modified release drug product as per FDA for the assessment of dose dumping? Is it required to compare against the reference product? If so, is it based on f2?

If the rate of in-vitro release in EtOH is not similar (i.e., faster but not the point of dose dumping) to that of the reference, then what?

Thanks

John
Shuanghe
★★  

Spain,
2012-05-17 12:08
(5138 d 06:53 ago)

@ jag009
Posting: # 8579
Views: 2,392
 

 FDA: In-Vitro Alcohol testing of modified release product

❝ Is it required to compare against the reference product? If so, is it based on f2?


yes. If you go to FDA's guidance page looking for new individual BE guidance for MR product, almost all of them require this test and:

"Both test and reference listed drug (RLD) products should be tested accordingly and data should be provided on individual unit, means, range and %CV on all strengths."

❝ If the rate of in-vitro release in EtOH is not similar (i.e., faster but not the point of dose dumping) to that of the reference, then what?


check this link.

http://www.aapsj.org/abstracts/am_2008/aaps2008-001832.pdf

I hope this helps.

Shuanghe

All the best,
Shuanghe
UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
128 visitors (0 registered, 128 guests [including 25 identified bots]).
Forum time: 19:01 CEST (Europe/Vienna)

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5